
Shaughnessy joins AMCP; APhA names new governance director

MSLs provide information and education to insurers and doctors but differ from sales representatives in their ability to provide peer-level interaction.

Medco claims that PolyMedica Corp. is the nation's largest provider of blood glucose testing supplies and related services to people with diabetes.

The grants are designed to reduce the number of annual hospital patient deaths from medical errors.

Humana is waiving its prescription refill rule for health plan members in three Minnesota counties damaged by flooding.

Studies have also shown that receiving the flu shot reduces death by 72% in diabetics aged 18 to 64 years.

The study, published recently in Drug Safety, looked at 650 patients who were experiencing side effects from statins and reported that 87% spoke to their doctors about a possible connection between a statin they had been prescribed and the symptom they experienced afterward.

Regence BlueCross BlueShield of Oregon has introduced a Generics First AntiDepressant Program.

Total costs to purchase prescription drugs under the Pittsburgh Business Group on Health's Prescription Drug Program increased just 3.7% in 2006, marking the third consecutive year of single-digit increases. PBGH is an employer-led coalition of more than 60 organizations.

NABP is now offering on-line applications for its Verified-Accredited Wholesale Distributors and Verified Internet Pharmacy Practice Sites programs.

In the 16 months that the Pharmacy Quality Alliance (PQA) has been in existence, it has developed an initial starter set of 37 measures to assess quality in pharmacy.

The "Just Ask!" campaign features a tool kit that can be used to urge patients to talk to hospital pharmacists when they have questions about their medications.


The American Thoracic Society has issued a checklist for parents to prevent asthma exacerbations and hospitalization in children as they head back to school.

The Lake Erie College of Osteopathic Medicine School of Pharmacy recently opened a new campus in Bradenton, Fla.

H.P.Acthar Gel is a natural form of adrenocorticotropic hormone, now cleared to treat multiple sclerosis exacerbations. Questcor Pharmaceuticals is also seeking approval for a new indication—to treat the orphan disease infantile spasms.

AmerisourceBergen's Orlando, Fla., distribution center is distributing controlled substances again.

Oxaliplatin (Eloxatin) will now be available in a new 200-mg single-use vial.

With damage to homes, businesses, and property estimated to be in the billions of dollars, Humana has temporarily lifted its normal 30-day restriction on early refills for flood victims in parts of Iowa, Ohio, and Wisconsin.

She will spearhead FMI's new pharmacy public affairs program, launched this year to strengthen industry advocacy on federal policy.

The American Thoracic Society has issued a checklist for parents to prevent asthma exacerbations and hospitalization in children as they head back to school.

Covering Kids and Families has issued a back-to-school campaign that includes thousands of activities, including health and enrollment fairs.

Former NACDS president and CEO Craig Fuller has joined the board of PharmMD.

Former NACDS president and CEO Craig Fuller has joined the board of PharmMD.

Ferring Pharmaceuticals commissioned a report on ways osteoarthritis costs are being managed.

Biopure Corp. has drafted a protocol for patients with life-threatening anemia for whom blood transfusion is not feasible to obtain its investigational product Hemopure (HBOC-201) on a compassionate-use basis.

U.S. Senator supports NACDS efforts to reduce burdensome Medication Guide (MedGuide) requirements for a growing number of prescriptions.

Baxter International is starting a program next year to provide continued access for patients relying on Gammagard Liquid and Gammagard S/D immune globulin intravenous-Human.

Three developments will have a major impact on the pharmaceutical market going forward.

NACDS president and CEO Steven Anderson praised endorsement letters the U.S. Chamber of Commerce has written to Congress, noting that they are an indication that the damaging Medicaid prescription drug reimbursement rule is a top-tier issue that requires a Congressional response.